| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Dev. &Ops. Officer | Chief Development Officer
1 company
Shemesh Shay serves as a Chief Dev. &Ops. Officer at NVCT. Across recent SEC filings that breaks down to 18 buys and 0 sells. Those positions are worth an estimated $40.1M at current prices.
Historically, Shemesh Shay's trades have earned a strong insider score of 72/100 across 16 rated trades. Over a 12-month horizon, 68.8% of those trades were profitable, with an average 12-month return of +28.6%.
The biggest single holding is NVCT (~$40.1M) as Chief Dev. &Ops. Officer. Net of sales, the recent Form 4 record there shows accumulation of 11,399 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 1,113 | $6.32 | $7,034.16 | - | +6.9% | +40.5% | |
| Mar 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 420 | $11.99 | $5,035.80 | - | +45.6% | -29.2% | |
| Mar 15, 2023 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 670 | $10.71 | $7,175.70 | - | +67.9% | -16.5% | |
| Dec 21, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 500 | $7.65 | $3,825.00 | - | +68.2% | +9.8% | |
| Nov 17, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 300 | $7.15 | $2,145.00 | - | +43.7% | +13.9% | |
| Sep 23, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 220 | $7.87 | $1,731.40 | - | -6.1% | +77.1% | |
| Sep 2, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 404 | $8.31 | $3,357.24 | - | -8.4% | +78.5% | |
| Sep 1, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 3,006 | $8.07 | $24,258.42 | +0.1% | -9.4% | +82.5% | |
| May 20, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 300 | $16.54 | $4,962.00 | - | -43.3% | +9.6% | |
| May 17, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 242 | $19.44 | $4,704.10 | - | -54.5% | -16.8% |